Abstract
Enzymes from thermophilic organisms are interesting biocatalysts for a wide variety of applications in organic synthesis, biotechnology, and molecular biology. Next to an increased stability at elevated temperatures, they were described to show a wider substrate spectrum than their mesophilic counterparts. To identify thermostable biocatalysts for the synthesis of nucleotide analogs, we performed a database search on the carbohydrate and nucleotide metabolism of Thermotoga maritima. After expression and purification of 13 enzyme candidates involved in nucleotide synthesis, these enzymes were screened for their substrate scope. We found that the synthesis of 2′-deoxynucleoside 5′-monophosphates (dNMPs) and uridine 5′-monophosphate from nucleosides was catalyzed by the already known wide-spectrum thymidine kinase and the ribokinase. In contrast, no NMP-forming activity was detected for adenosine-specific kinase, uridine kinase, or nucleotidase. The NMP kinases (NMPKs) and the pyruvate-phosphate-dikinase of T. maritima exhibited a rather specific substrate spectrum for the phosphorylation of NMPs, while pyruvate kinase, acetate kinase, and three of the NMPKs showed a broad substrate scope with (2′-deoxy)nucleoside 5′-diphosphates as substrates. Based on these promising results, TmNMPKs were applied in enzymatic cascade reactions for nucleoside 5′-triphosphate synthesis using four modified pyrimidine nucleosides and four purine NMPs as substrates, and we determined that base- and sugar-modified substrates were accepted. In summary, besides the already reported TmTK, NMPKs of T. maritima were identified to be interesting enzyme candidates for the enzymatic production of modified nucleotides.
Keywords: Thermotoga maritima, nucleotide analogs, nucleoside/nucleotide kinase, nucleotide metabolism, ribokinase, pyruvate kinase, acetate kinase, pyruvate-phosphate-dikinase, nucleotidase, thermostable, substrate specificity
Natural and modified nucleotides are widely used as drugs to treat cancer or viral infections (1), food additives (2), or as reagents for molecular biology applications (3). Recently, they have contributed significantly to the containment of the Corona pandemic as building blocks of mRNA vaccines (4) or important components of PCR-based diagnostic kits (5).
Nucleotide analogs are mainly synthesized chemically. In contrast to the chemical synthesis routes, biocatalytic approaches offer several advantages: reactions can be performed at milder conditions, the use of harsh solvents is reduced, and the use of protection groups can be avoided due to a high regioselectivity and stereoselectivity (6, 7). For the biocatalytic nucleotide synthesis, enzymes of the de novo and salvage nucleotide pathway of various organisms were studied. These include, among others, phosphoribosyltransferases (PRTs), nucleoside kinases (NKs), nucleoside monophosphate kinases (NMPKs) and nucleoside diphosphate kinases (NDPKs). We recently developed a general approach for the one-pot synthesis of nucleoside triphosphates from nucleosides using nucleoside and nucleotide kinases (8). By coupling the phosphorylation reactions with an adenosine triphosphate (ATP) regeneration system, yields were significantly improved (8). Lately, cladribine triphosphate, a drug against leukemia and multiple sclerosis, was synthesized from 2-chloroadenine and phosphoribosyl pyrophosphate by an adenine phosphoribosyltransferase, polyphosphate kinase, and ribonucleotide reductase (9). In this cascade reaction, polyphosphates served as a low-cost phosphate donor.
Although enzymes from thermophilic organisms show many favorable characteristics like high thermal or solvent stability and broader substrate spectra compared to their mesophilic counterparts (10, 11, 12), to date only a few thermostable nucleoside or nucleotide phosphorylating enzymes were characterized (13). Enzymes accepting nucleosides or nucleoside diphosphates (NDPs) as substrates exhibited a broader substrate spectrum than NMPKs (Tables S1–S3). Interestingly, three classes of enzymes were described to phosphorylate nucleosides and exhibit a wide substrate spectrum: broad specificity NK (EC 2.7.1.B20), family B 6-phosphofructokinase (PfkB, EC 2.7.1.11), and thymidine kinases (TK, EC 2.7.1.21) (14, 15, 16, 17, 18). While TK predominantly accepted deoxyribonucleosides (Table S1), the NKs and PfkB preferred ribonucleosides (Table S1). An interesting finding for TK of Thermotoga maritima (TmTK) was that it shows a wide substrate spectrum, which however differed depending on the reaction temperature applied (18). TmTK accepted a wide range of modified nucleosides like 2′,3′-dideoxythymidine, 5-fluoro-2′-deoxyuridine, 2′,3′-dideoxy-3′-azidothymidine, 2′,3′-dideoxy-2′,3′-didehydrothymidine, 2′-fluoro-5-methyl-β-L-arabinofuranosyl-uracil, and dioxolane thymidine.
Inspired by the broad substrate scope of TmTK, we studied the enzymes involved in nucleotide synthesis in the hyperthermostable bacterium T. maritima with the aim of identifying additional wide spectrum enzymes for biocatalytic applications. In total, 13 enzymes of T. maritima were expressed, purified, and characterized. The substrate scope of active enzymes was analyzed using a set of 26 natural (deoxy)nucleosides or nucleotides as substrates. Finally, we demonstrated the synthesis of base- and sugar-modified nucleotides in cascade reactions with T. maritima NMPKs. Thus, this study presents a set of thermostable TmNMPKs suitable for the synthesis of natural and modified nucleotides.
Results and discussion
Identification of enzymes capable of phosphorylating nucleosides, NMPs, and NDPs in T. maritima
To identify enzymes of T. maritima involved in the phosphorylation of nucleosides, we analyzed both the Kyoto Encyclopedia of Genes and Genomes (KEGG) database and the T. maritima genome (Figs. 1 and S1). Next to the known TmTK (18), in the genome an adenosine-specific kinase (TmAsK) and a three-domain uridine kinase (TmUK, annotated as NK in the genome sequence) were found. Adenosine-specific kinases are rarely studied, and the TmUK shows an unusual protein sequence as it consists of a NK superfamily domain and a threonyl-tRNA synthetase domain (Fig. S2A). Neither a deoxycytidine kinase, a (deoxy)adenosine kinase, an inosine kinase, deoxyguanosine kinase, nor a deoxynucleoside kinase was found in T. maritima (Figs. 1 and S1).
Figure 1.
Overview on enzymes potentially involved in the nucleotide salvage pathway of T. maritima. Biocatalysts were identified on the one hand by analyzing the T. maritima specific KEGG pathway (black font color, bold, italic) in comparison to the corresponding reference pathway (gray font color). On the other hand, the T. maritima genome was screened for kinases described in the literature for accepting nucleosides or nucleotides as substrates (blue background). All enzymes marked in bold and italics were expressed, purified, and biochemically characterized in this study. Ado, adenosine; AK, adenosine kinase; AK3, isozyme 3 of adenylate kinase; AMPK, adenylate kinase; AsK, adenosine-specific kinase; CK, cytidine kinase; Cyd, cytidine dAdo, 2′-deoxyadenosine; (d)ADP, (2′-deoxy)adenosine 5′-diphosphate; dAK, deoxyadenosine kinase; (d)AMP, (2′-deoxy)adenosine 5′-monophosphate; dAMPK, deoxyadenylate kinase; (d)ATP, (2′-deoxy)adenosine 5′-triphosphate; (d)CDP, (2′-deoxy)cytidine 5′-diphosphate; dCK, deoxycytidine kinase; (d)CMP, (2′-deoxy)cytidine 5′-monophosphate; (d)CMPK, (deoxy)cytidylate kinase; dCyd, 2′-deoxycytidine; (d)GDP, (2′-deoxy)guanosine 5′-diphosphate; (d)GMP, (2′-deoxy)guanosine 5′-monophosphate;dGuo, 2′-deoxyguanosine; (d)NTP, (2′-deoxy)nucleoside 5′-triphosphate; (d)UDP, (2′-deoxy)uridine 5′-diphosphate; dUMP, 2′-deoxyuridine 5′-monophosphate; dUrd, 2′-deoxyuridine; GMPK, guanylate kinase; Guo, guanosine; IK, inosine kinase; NDPK, nucleoside diphosphate kinase; Nuc, nucleotidase; PK, pyruvate kinase; PPDK, pyruvate-phosphate-dikinase; RK, ribokinase; TDP, thymidine 5′-diphosphate; Thd, thymidine, TK, thymidine kinase; TMP: thymidine 5′-monophosphate; TMPK, deoxythymidylate kinase; UK, uridine kinase; UMP, uridine 5′-monophosphate; UMPK, uridylate kinase; Urd, uridine.
As other enzyme classes like nucleotidases (19), acid phosphatases (20), PfkB (15, 16, 21), or polyphosphate kinases (22) are also known for the phosphorylation of nucleosides or nucleotides, they were also included in this study. Indeed, the KEGG pathway for the purine nucleotide metabolism suggests that the 5′/3′-nucleotidase SurE (TmNuc, also classified as acid phosphatase) of T. maritima (23) might catalyze the formation of purine NMPs (Fig. 1) which led us to integrate this enzyme into our study. Additionally, the T. maritima genome encodes for six enzymes of the PfkB-family including a ribokinase (24). Ribokinase of T. maritima (TmRK) was described to show a high structural similarity to the NK of Methanocaldococcus janaschii (21) which accepted all natural ribonucleosides (15). Therefore, the TmRK was selected in this study to evaluate whether it can accept nucleosides as substrates. Other PfkB-family enzymes were excluded from this study as they were shown before to be very specific for their sugar substrate (24).
For the second phosphorylation step, five NMPKs, namely an adenylate kinase (TmAMPK), a guanylate kinase (TmGMPK), an uridylate kinase (TmUMPK), a deoxythymidylate kinase (TmTMPK), and a (deoxy)cytidylate kinase (Tm(d)CMPK) were identified (Fig. 1). Additionally, in the genome, a pyruvate-phosphate-dikinase (TmPPDK) was found. This enzyme was described before to catalyze the phosphorylation of nucleoside monophosphates directly to nucleoside triphosphates using phosphoenolpyruvate and pyrophosphate as substrates (25).
The conversion of NDPs to nucleoside 5′-triphosphates (NTPs) usually is catalyzed by wide-spectrum NDPKs. Surprisingly, the genome of T. maritima does not encode for a NDPK. Therefore, we included enzymes capable of performing a similar function as NDPKs in this study. We focused on enzymes widely used for ATP regeneration as they are well known to catalyze NTP formation. Furthermore, it was shown that pyruvate kinase is a candidate for a phosphoenolpyruvate (PEP)-dependent NDP kinase activity in Escherichia coli and L. lactis due to a wide substrate scope (26). Studying the T. maritima genome, an acetate kinase (TmAcK) (27) and a pyruvate kinase (TmPK) (28) were identified. A polyphosphate kinase, however, was not identified in the genome of T. maritima (29).
To explore whether the substrate specificities correlate with gene annotation, the 13 described enzymes putatively involved in the phosphorylation of nucleosides, NMPs, or NDPs (Fig. 1) were expressed, purified, and characterized in a next step.
Expression and thermal characterization of the T. maritima enzymes
After gene synthesis, all T. maritima enzymes were successfully expressed in E. coli Iq cells and purified by affinity chromatography (Fig. S3). Protein yields were in the range of 0.8 to 15 mg g−1 cell pellet wet weight.
One advantage of thermostable enzymes is the possibility to use a heat treatment step to enhance protein purification. For TmTK and TmPK heat steps at 70 to 80 °C for 20 to 30 min were already described (18, 28). To confirm the thermostability of all expressed enzymes, we analyzed the heat denaturation of the enzymes purified by affinity chromatography in a thermal shift assay at pH values of 7, 8, and 9 in the absence and presence of 1,4-dithiothreitol (DTT). Indeed, no denaturation of the enzymes was detected up to 95 °C and during an additional 20 min incubation step at 95 °C (Fig. S4). Since the enzymes were shown to be hyperthermostable, they were re-expressed and purified by heat treatment and affinity chromatography.
Activity testing of the T. maritima enzymes at varying pH
Having purified enzymes in hand, activity was determined at 37 °C using their putative natural nucleoside or nucleotide substrates. Phosphotransferase activity was confirmed for all enzymes except for TmNuc, TmUK, and TmAsK. As nucleosides are not the natural substrates for nucleotidase, additional activity tests were performed with adenosine 5′-nucleotides, and phosphatase activity toward adenosine 5′-monophosphate (AMP) (23) and adenosine 5′-diphosphate (ADP) was shown (data not shown). Hence, TmNuc is not able to phosphorylate nucleosides under the applied conditions.
Studies on adenosine-specific kinase (AsK) are rare. The first described enzyme was PAE2307, a protein from the hyperthermophilic archaeon Pyrobaculum aerophilum (30). Structural studies in combination with fluorescence spectroscopic analysis indicated a binding of adenosine and AMP to the adenosine-specific kinase like protein. Furthermore, a phosphorylation of the conserved histidine residue in the putative substrate-binding site was observed. Hence, it was suggested that the enzyme is a new class of adenosine kinase. Therefore, we evaluated if TmAsK can phosphorylate adenosine. However, no AMP-forming activity was observed (data not shown). As biochemical and structural studies on a homologous enzyme of Thermus thermophilus indicated that the enzymatic function of the “adenosine-specific kinase” family is rather an ADP cleavage to AMP (31), we evaluated if the TmAsK shows ADP phosphatase activity. However, no activity was observed using ADP as substrate for TmAsK (data not shown). Additionally, no phosphatase activity was detected with AMP and ATP. Since MgCl2 was described to inhibit phosphatase activity of AsK (31), reactions were also performed without the addition of MgCl2 and DTT. However, no activity was detected as well (data not shown). Thus, neither a phosphotransferase nor a phosphatase activity was shown for TmAsK under the conditions tested.
The TmUK was described before to be a result of interkingdom gene fusions, which is shared by Treponema pallidum and T. maritima (32). Using the full-length protein, no UK activity was observed in this study (Fig. S2). However, ATP phosphatase activity was observed in the presence of uridine (Urd). Therefore, we decided to study if truncated versions (TmUKs1-4, Fig. S2) only coding for the UK domain would show Urd phosphorylation activity. Truncated UK variants were cloned, heterologously expressed in E. coli and purified by affinity chromatography. While TmUKs1-3 were produced in substantial amount and with good purity, TmUKs4 could not be produced since only insoluble protein was obtained. Activity testing with Urd as substrate revealed no formation of uridine 5′-monophosphate (UMP) with all truncated UK variants. These results together with the observed ATP phosphatase activity in the presence of Urd fit well to the hypothesis that the three-domain UK of T. pallidum and T. maritima are involved in the autoregulation of translation (32).
For all enzymes showing phosphorylating activity toward nucleosides or nucleotides working pH ranges were determined, except for TmTK, TmPK, TmAcK, and TmPPDK. For the latter enzymes, the optimal reaction pH has already been described ((18, 25, 27, 28), Table 1). Working pH ranges differed depending on the enzyme classes. While TmPK and TmAcK preferred a lower reaction pH, TmTK, TmRK, and nearly all TmNMPKs (except for Tm(d)CMPK) showed a comparable activity in a pH range of 7 to 9 (Table 1 and Fig. S5).
Table 1.
Working pH range of the studied T. maritima enzymes involved in nucleotide synthesis
| Enzyme | pH range | Reference |
|---|---|---|
| PfkB family | ||
| TmRK | 7–9a | This study |
| Nucleoside kinases | ||
| TmTK | 7–9 | (18) |
| NMP kinases | ||
| TmAMPK | 7–9a | This study |
| Tm(d)CMPK | 7–8a | This study |
| TmGMPK | 7–9a | This study |
| TmTMPK | 7–9a | This study |
| TmUMPK | 7–9a | This study |
| TmPPDK | 7.0–7.5b | (25) |
| NDP kinases | ||
| TmPK | 6.0b | (28) |
| TmAcK | 7.0b | (27) |
The working pH ranges were determined by comparing specific activities (Fig. S5). Reactions with 2 mM MgCl2, 5 mM DTT, 50 mM KCl, 1 mM substrate (AMPK: dAMP, (d)CMPK: CMP, GMPK: GMP, RK: Urd, TMPK: TMP, UMPK: UMP), and 1.2 mM ATP in 70 mM Tris-HCl (pH 7, 8, 9) were preheated to 37 °C. Reactions were started with appropriate enzyme dilutions. Samples were stopped after 5 min incubation with cold deionized water and were analyzed by the luminescent assay.
Optimal pH.
Evaluation of the substrate scope
To validate the substrate scope of the enzymes phosphorylating either nucleosides or nucleotides, reactions with 26 natural nucleosides or nucleotides were performed and analyzed by either thin-layer chromatography (TLC) or high-performance liquid chromatography (HPLC) after an incubation time of 19 h at 37 °C.
TmTK was described to be specific for thymidine and uridine derivatives (18). In our study, TmTK accepted all deoxynucleosides and uridine, with 2′-deoxyadenosine being the worst substrate (Fig. 2A).
Figure 2.
Substratescope ofTmRK,TmTK,TmNMPKs and TmPPDK. Reactions were performed under standard conditions: 70 mM Tris-HCl pH 7.6, 2 mM MgCl2, 5 mM DTT, 50 mM KCl, 1.2 mM phosphate donor and 1 mM nucleoside (TmRK, TmTK, A) or NMP (TmNMPKs and TmPPDK, B). As phosphate donors ATP or dATP (for AMP reactions) were applied, except for TmPPDK, where PEP and Na4O7P2 were used. Reactions were incubated for 19 h at 37 °C. Samples were analyzed by HPLC. Ado, adenosine; AMP, adenosine 5′-monophosphate; AMPK, adenylate kinase; CMP, cytidine 5′-monophosphate; Cyd, cytidine; dAdo, 2′-deoxyadenosine; dAMP, 2′-deoxyadenosine 5′-monophosphate; dATP, 2′-deoxyadenosine 5′-triphosphate; dCMP, 2′-deoxycytidine 5′-monophosphate; (d)CMPK, (deoxy)cytidylate kinase; dCyd, 2′-deoxycytidine; dGMP, 2′-deoxyguanosine 5′-monophosphate; dGuo, 2′-deoxyguanosine; dIno, 2′-deoxyinosine; DTT, 1,4-dithiothreitol; GMP, guanosine 5′-monophosphate; GMPK, guanylate kinase; Guo, guanosine; HPLC, high-performance liquid chromatography; Ino, inosine; NMPK, nucleoside monophosphate kinase; PEP, phosphoenolpyruvate; PPDK, pyruvate-phosphate-dikinase; RK, ribokinase; Thd, thymidine; TK, thymidine kinase; Tm, Thermotoga maritima; TMP, thymidine 5′-monophosphate; TMPK, deoxythymidylate kinase; UMP, uridine 5′-monophosphate; UMPK, uridylate kinase; Urd, uridine.
The substrate spectrum of TmRK with a set of sugars was studied before, and it was shown that the enzyme is very specific for D-ribose (24). Although TmRK seems to be a rather specific sugar kinase, it phosphorylates the natural nucleosides thymidine and uridine as well as deoxyguanosine, deoxyinosine, and deoxycytidine albeit with lower conversion (Fig. 2A). The preference for pyrimidine nucleosides is in good accordance with Pyrobaculum caldifontis PfkB, which preferred cytidine and uridine (16). Interestingly, while other PfkB members preferred ribonucleosides (15, 16), TmRK seems to prefer deoxynucleosides.
NMPKs of T. maritima showed a rather narrow substrate scope, except for TmUMPK which accepted all natural riboNMPs (Fig. 2B). The other NMPKs accepted their preferred substrate next to a few additional substrates. As an example, Tm(d)CMPK accepted cytidine 5′-monophosphate (CMP), 2′-deoxycytidine 5′-monophosphate, and UMP.
Interestingly, all NMPKs, except for UMPK, converted the NMP substrates to the respective NTPs with an NDP as intermediate (Fig. 3). Based on these results, we tested the ability of the NMPKs to accept NDPs as substrates with ATP as phosphate donor. Indeed, TmAMPK, TmGMPK, and Tm(d)CMPK were able to catalyze NTP formation with all tested natural (d)NDPs (Fig. 3). TmTMPK and TmUMPK catalyzed (d)ATP formation, and TmTMPK additionally converted thymidine 5′-diphosphate to thymidine 5′-triphosphate. Thus, T. maritima NDPK deficiency might be compensated by TmAMPK, TmGMPK, and Tm(d)CMPK. NDPK activity of NMPKs has already been described before for diverse adenylate kinase (AMPKs) (33, 34, 35) and human UMP-CMPK (34). Human NMPKs were described to show real NDPK activity () (34). In contrast, NDPK activity of bacterial AMPKs was explained by the commonly known reversibility of the NMPK reaction () (33, 34, 35).
Figure 3.
Substrate scope of TmNMPKs, TmPPDK, TmAcK, and TmPK using NDPs as substrates. Reactions were performed under standard conditions (70 mM Tris-HCl pH 7.6, 2 mM MgCl2, 5 mM DTT, 50 mM KCl, 1 mM substrate, 1.2 mM phosphate donor) either with (+) or without (−) phosphate donor. As phosphate donors ATP or dATP (for AMP reactions) for TmNMPKs, PEP for TmPK, AcetylP for TmAcK, as well as PEP and Na4O7P2 for TmPPDK were applied. Reactions were incubated for 19 h at 37 °C, and samples were analyzed by HPLC. AcK, acetate kinase; AcetylP, acetyl phosphate; ADP, adenosine 5′-diphosphate; AMPK, adenylate kinase; CDP, cytidine 5′-diphosphate; dADP, 2′-deoxyadenosine 5′-diphosphate; dATP, 2′-deoxyadenosine 5′-triphosphate; dCDP, 2′-deoxycytidine 5′-diphosphate; (d)CMPK, (deoxy)cytidylate kinase; dGDP, 2′-deoxyguanosine 5′-diphosphate; DTT, 1,4-dithiothreitol; GDP, guanosine 5′-diphosphate; GMPK, guanylate kinase; HPLC, high-performance liquid chromatography; NDP, nucleoside 5′-diphosphate; NMP, nucleoside 5′-monophosphate; NMPK, nucleoside monophosphate kinase; NTP, nucleoside 5′-triphosphate; PEP, phosphoenolpyruvate; PK, pyruvate kinase; PPDK, pyruvate-phosphate-dikinase; TDP, thymidine 5′-diphosphate; Tm, Thermotoga maritima; TMPK, deoxythymidylate kinase; UDP, uridine 5′-diphosphate; UMPK, uridylate kinase.
As for some reactions using NDPs as substrates and NTPs as phosphate donor, NMP formation was detected, we validated whether NMP formation is the result of the reverse NMPK reaction or based on basal NDP cleaving activity of the enzyme preparation. Reactions were performed with NDP as substrate, but without ATP. Indeed, with some substrates, NMPKs (except for UMPK) were able to catalyze the reaction . Accepted substrates correlated well with the NMP preference of the enzymes (Fig. 3). As an example, Tm(d)CMPK converted (d)CDP and UDP to the corresponding NMP and NTP.
TmPPDK only converted AMP and 2′-deoxyadenosine 5′-monophosphate to the respective NTPs with (d)ADP formed as by-products to a lower percentage (Fig. 2B). Additionally, it was shown that (d)ADP and (d)GDP were substrates of TmPPDK with comparable efficiency (Fig. 3). In good agreement with our results, TmPPDK was described before to be highly specific for AMP when tested with ribonucleotide monophosphates (25). However, little information is available on the substrate scope of PPDKs since mainly reactions with AMP as substrate were reported. For Clostridium symbiosum PPDK, even an inhibitory effect of other NMPs like guanosine 5′-monophosphate (GMP) and inosine 5′-monophosphate was shown (36).
In contrast to TmPPDK, TmPK and TmAcK accepted all natural riboNDPs and deoxyriboNDPs (Fig. 3). While TmPK showed a preference for purine NDPs, TmAcK converted all NDPs with comparable high conversion. Our results fit well to the observation that TmAcK accepts ATP, guanosine 5′-triphosphate, inosine 5′-triphosphate, uridine 5′-triphosphate (UTP), and cytidine 5′-triphosphate as phosphate donors for acetyl phosphate (AcetylP) synthesis (27). PKs and acetate kinase (AcKs) are well known to show a wide substrate scope with PK and AcK of Geobacillus stearothermophilus being good examples. GsPK was described to accept all natural riboNDPs ADP, guanosine 5′-diphosphate, inosine 5′-diphosphate, UDP and cytidine 5′-diphosphate, with the latter being the worst substrate (37). GsAcK was studied in the direction of AcetylP synthesis, and ATP, guanosine 5′-triphosphate, UTP, and cytidine 5′-triphosphate were shown to serve as phosphate donors (38). Purine NTPs were preferred over pyrimidine NTPs.
In summary, T. maritima is able to synthesize all natural 5'-(d)NTPs starting from the respective (d)NMPs, although it does not possess a NDPK (Fig. S1). The majority of NMPKs as well as TmAcK and TmPK are able to phosphorylate NDPs to NTPs. Furthermore, TmPPDK either converts (d)AMP to (d)ATP or (d)ADP and 2′-deoxyguanosine 5′-diphosphate to the corresponding (d)NTPs. Due to the presence of the wide-spectrum TK and the RK, phosphorylation of deoxynucleosides and uridine to the respective monophosphates is possible. A nucleoside kinase for the synthesis of riboNMPs, however, seems not to be present in T. maritima (Fig. S1). Though, in purine metabolism, enzymes of the complete de novo pathway are present, so that the synthesis of AMP and GMP is possible via this route (Fig. S1). In addition, the genome of T. maritima also contains PRT for adenine and hypoxanthine which catalyze the synthesis of AMP and GMP starting from the corresponding bases. However, based on the available data, the synthesis of CMP starting from cytidine or cytosine is not possible in T. maritima, since corresponding enzymes are missing (Fig. S1). Though, probably the salvage of CMP is catalyzed via TmNuc or deamination to uridine by cytidine deaminase.
Enzymatic cascade reaction to synthesize 5′-NTP analogs
With the initial aim in mind to produce 5′-NTP analogs, we evaluated whether TmNMPKs accept nucleotide analogs as substrates (Figs. 4, S6 and S7). Therefore, enzyme reactions with ATP as phosphate donor were run for 19 h at 37 °C, and samples were either analyzed by TLC or HPLC. The NMP analogs 2-chloro-AMP, vidarabine phosphate, fludarabine phosphate, and cytarabine phosphate (araCMP) were tested as substrates for the TmNMPKs. As NMPs were not available for pyrimidine analogs and for arabinofuranosylguanine, we screened the TmNMPKs in cascade reactions with the wide spectrum NKs Drosophila melanogaster deoxynucleoside kinase (DmdNK) or human uridine-cytidine kinase 2 (HsUCK2, NK15) for the phosphorylation of 5-bromouridine, 5-fluoro-2′-deoxyuridine, arabinofuranosyluracil, and arabinofuranosylguanine. To enhance the synthesis of the NTPs (8), an ATP regeneration system based on TmAcK was integrated.
Figure 4.
Enzyme cascade reactions for the synthesis of 5′-nucleotide analogs.A and B, enzyme cascade reactions were performed with 10 mM MgCl2, 5 mM DTT, 50 mM KCl, 1 mM NMP (A) or nucleosides (B), 1.2 mM ATP, 5 mM AcetylP in 70 mM Tris-HCl pH 7.6. Enzymes were applied with 0.02 mg ml−1 NK (HsUCK2: 5-Br-Urd, others: DmdNK) 0.04 mg ml−1 NMPK and 0.02 mg ml−1 AcK. Cascade reactions were incubated for 19 h at 37 °C and analyzed by TLC or HPLC (see Figs. S6 and S7). (+) <10% NDP formation, (++) NDP formation between 10% and 50%, + <10% NTP formation, ++ NTP formation between 10% and 50%, +++ NTP formation >50%. 2-Cl-AMP, 2-chloro-adenosine 5′-monophosphate; 2-F-araAMP, fludarabine phosphate; 5-Br-Urd, 5-bromo-uridine; 5-F-dUrd, 5-flouro-2′-deoxyuridine; AcK, acetate kinase; AcetylP, acetyl phosphate; ADP, adenosine 5′-diphosphate; AMPK, adenylate kinase; araAMP, vidarabine phosphate; araCMP, cytarabine phosphate; araGuo, arabinofuranosylguanine; CMPK, (deoxy)cytidylate kinase; DmdNK, Drosophila melanogaster deoxynucleoside kinase; DTT, 1,4-dithiothreitol; GMPK, guanylate kinase; HPLC, high-performance liquid chromatography; HsUCK2, human uridine-cytidine kinase 2; NDP, nucleoside 5′-diphosphate; NMPK, nucleoside monophosphate kinase; Tm, Thermotoga maritima; TMPK, deoxythymidylate kinase; UMPK, uridylate kinase.
All modified substrates tested were at least accepted by one TmNMPK (Figs. 4, S6 and S7), which indicates their high potential for the in vitro synthesis of nucleotide analogs. So far, mainly NMPKs from human and pathogenic organisms were studied for their ability to phosphorylate nucleotide analogs, since they are responsible for the therapeutic efficiency of nucleoside/nucleotide drugs (39, 40, 41, 42). Apart from that, there are only few reports about nucleotide analog synthesis involving NMPKs, including the synthesis of 3′-F-(d)ATP and 3′F-(d)GTP by yeast NMPKs (43), several 2′-/3′-modified NMPs by calf thymus NMPKs (44), 5-F-CTP, 5-F-UTP by E. coli NMPKs (45), as well as adenosine 5′-(O-1-thiotriphosphate), adenosine 5′-(O-2-thiotriphosphate), and ribavirin triphosphate by rabbit muscle AMPK (46, 47). Notably, to our best knowledge, we demonstrated here for the first time the acceptance of nucleotide analogs by thermostable NMPKs.
For TmAMPK, NTP formation was observed for all AMP analogs (Fig. 4). Interestingly, although CMP and UMP are natural substrates, araUMP was accepted but not araCMP. Furthermore, neither the other UMP analogs nor araGMP were phosphorylated. The preference of AMP analogs is in good agreement with the data for other AMPKs (8, 48, 49). In contrast to the phosphorylation of deoxycytidine analogs like araCMP (48), the acceptance of araUMP was not described before for AMPKs.
Tm(d)CMPK converted the sugar-modified substrates araCMP, araGMP, and araUMP, but not the AMP analogs and the base-modified UMP analogs (Fig. 4). Besides araCMP, 2′-3′-dideoxy-CMP was a substrate for E. coli CMPK (50). Whereas the E. coli CMPK accepted sugar- and base-modified analogs of pseudouridine monophosphate (51), TmCMPK was not phosphorylating the 5-halogenated UMP analogs.
TmGMPK phosphorylated the sugar-modified NMPs araGMP, vidarabine phosphate, and araUMP (Fig. 4). However, neither the base-modified adenosine nor the uridine analogs were substrates of TmGMPK. Guanylate kinase (GMPKs) were described before to accept guanosine analogs like araGMP and 2′-2′-difluorodeoxyguanosine monophosphate for DmGMPK (52), as well as 8-azaGMP, ganciclovir, and acyclovir for human erythrocyte GMPK (53, 54, 55).
In contrast to the other three TmNMPKs, all uridine analogs were accepted by TmTMPK and TmUMPK (Fig. 4). Notably, for 5-Br-UMP only the diphosphate was detected. This might be explained by the substrate scope observed for both NMPKs. Neither of the two enzymes was able to convert UDP to UTP (Fig. 3). Interestingly, for the other uridine analogs, the triphosphate was formed. Thus, TmAcK very likely accepted the modified uridine diphosphates, except for 5-Br-UDP, as substrates.
In summary, we demonstrated the ability of the T. maritima NMPKs to phosphorylate base- and sugar-modified substrates in enzymatic cascade reactions. Thus, they are interesting thermostable biocatalysts for the in vitro synthesis of modified 5′-nucleotides.
Conclusions
In this study, we investigated 13 enzymes of T. maritima for their ability to phosphorylate natural and modified nucleosides or nucleotides. Three of the enzymes, namely TmAsK, TmUK, and TmNuc, did not show phosphotransferase activity with ATP as phosphate donor under the conditions tested. Broad substrate spectra toward natural substrates were shown for TmTK, TmPK, and TmAcK, whereas TmPPDK and TmRK were more specific. While all five TmNMPKs had a narrow substrate scope toward NMPs, we detected a broad NDPK activity for three TmNMPKs. In addition, we demonstrated for the first time the phosphorylation of base- and sugar-modified NMPs by thermostable NMPKs in enzymatic cascade reactions. While we focused on modifications in the 2′-position of the ribosyl residue or the 5-position of the base, the synthesis of further modifications can be analyzed in the future. Of particular interest here could be 3′- or 4′-modified nucleotides or C-nucleotides. Thus, our work lays the foundation for the application of these thermostable enzymes for the biocatalytic production of nucleotide analogs.
Experimental procedures
General information
All chemicals and solvents were of analytical grade or higher and purchased from Sigma-Aldrich, Carl Roth, TCI Deutschland, Carbosynth, or VWR. Nucleosides and nucleotides were acquired from Alfa Aesar, Carl Roth, Sigma-Aldrich, Carbosynth Limited, and TCI. Stock solutions with concentrations of 10 and 50 mM were prepared in deionized water, and aliquots were stored at −20 °C.
The human uridine-cytidine kinase 2 (HsUCK2, NK15) was kindly provided by BioNukleo GmbH and stored at −20 °C.
Identification of enzymes involved in the nucleotide salvage pathway of T. maritima
The KEGG pathway of T. maritima in comparison to the reference pathway was analyzed (purine metabolism: tma00230 and pyrimidine metabolism: tma00240). All enzymes involved in the nucleotide pathway were chosen for gene synthesis. Furthermore, the genome of T. maritima (accession number: NC_023151.1) was analyzed for proteins being able to phosphorylate either nucleosides, NMPs, or NDPs.
Expression and purification of the T. maritima enzymes
Genes of interest were synthesized by GeneArt (ThermoFisher). Enzymes were expressed in E. coli Iq (NEB) using EnPresso B medium (Enpresso) based on the manufacturer’s recommendations. Briefly, a 50 ml main culture was inoculated either from a fresh transformation plate or an LB preculture. Protein expression was induced by the addition of 200 μM IPTG. Cells were harvested by centrifugation and stored at −20 °C until further use. For purification, the cell pellet was resuspended in binding buffer (50 mM NaH2PO4, 300 mM NaCl, 10 mM imidazole, pH 8), including 0.1 mM phenylmethylsulfonyl fluoride, 1 mg ml−1 lysozyme, 1 mM MgCl2, and 0.6 mg ml−1 DNase. After incubation for 30 min at room temperature, cells were disrupted by sonification and prepurified by heat treatment for 20 min at 80 °C. After centrifugation, the clear supernatant was loaded onto 0.5 to 2 ml Ni-NTA agarose (Jena Bioscience) columns. The columns were washed four times with 2 column volumes of washing buffer (binding buffer with 20 mM imidazole) and six times with 0.5 column volumes of elution buffer (binding buffer with 250 mM imidazole). The buffer of the elution fractions was exchanged by dialysis to 50 mM Tris-HCl pH 7.6, and enzymes were stored in 50% (v/v) glycerol at −20 °C.
The purity of the enzyme preparations was analyzed by SDS-PAGE. Protein concentration was determined by A280 measurements at a ThermoFisher Scientific NanoDrop One using the molar extinction coefficient E1% predicted by Protparam.
Expression and purification of the D. melanogaster deoxynucleoside kinase
The D. melanogaster deoxynucleoside kinase (DmdNK) plasmid was kindly provided by Prof. Birgitte Munch-Petersen (Roskilde University). The GST-fusion protein was produced as described before (8, 56) in E. coli BL21. The purified and tag-free enzyme was stored in 50% glycerol, 1% Triton X-100 and 1 mM DTT at −20 °C.
Thermal shift assay
The melting point was analyzed as described before (57). In a total volume of 25 μl, 0.2 g l−1 enzyme and 5× SYPRO orange were incubated in 70 mM Tris-HCl pH 7, pH 8, or pH 9 with 0 or 5 mM DTT. The sealed PCR plate was incubated at 50 °C for 30 s and then heated in steps of 0.5 °C per 5 s to a final temperature of 95 °C in a Bio-Rad CFX96 Real-Time system. Fluorescence was measured at λex = 470 nm and λem = 570 nm. To estimate protein stability at elevated temperatures, proteins were further incubated at 95 °C for 20 min. Fluorescence was measured again afterward. The melting point was determined as the inflection point of the fluorescence intensity over the temperature.
Enzyme activity assays
Enzyme reactions were performed in 50 to 200 μl volumes. Standard reaction mixtures consisted of 70 mM Tris-HCl pH 7.6, 2 mM MgCl2, 5 mM DTT, 50 mM KCl, 1 mM substrate (nucleoside, NMP or NDP), and 1.2 mM phosphate donor (ATP or 2′-deoxyadenosine 5′-triphosphate: NKs, NMPKs, RK; PEP: PK, PPDK; AcetylP: AcK) and 0.1 mg ml−1 enzyme. For the PPDK additionally, 1 mM sodium pyrophosphate (Na4O7P2) was applied.
Nucleoside phosphotransferase activity of Nuc was further tested as described before (19). Briefly, reactions including 1 mM 2′-deoxyinosine 2 mM inosine 5′-monophosphate, 20 mM MgCl2 and 4.5 mM ATP, and 0.1 mg ml−1 Nuc in 100 mM Tris-HCl pH 7.6 were performed. Additionally, reactions including 2 mM MgCl2, 5 mM DTT, 1 mM inosine, 1.2 mM GMP, 1.2 mM ATP, and 0.1 mg ml−1 enzyme in 70 mM Tris-HCl pH 7.6 were analyzed.
To analyze the nucleotide phosphatase activity of AsK and Nuc, the nucleotides AMP, ADP, and ATP were applied as substrates in the standard reaction mixture without an additional phosphate donor. AsK reactions were also performed without the addition of MgCl2 and/or DTT.
Reactions were incubated for 19 h at 37 °C and validated by TLC or HPLC.
Enzyme cascade reactions were performed with 10 mM MgCl2, 5 mM DTT, 50 mM KCl, 1 mM substrate (nucleoside or nucleotide), 1.2 mM ATP, and 5 mM AcetylP in 70 mM Tris-HCl pH 7.6. Enzymes were applied with 0.02 mg ml−1 NK, 0.04 mg ml−1 NMPK, and 0.02 mg ml−1 AcK. Cascade reactions were incubated for 19 h at 37 °C and analyzed by TLC or HPLC.
Determination of the reaction pH
The influence of the reaction pH was evaluated by applying 70 mM Tris-HCl pH 7, 8, and 9. The following substrates were used: Urd: RK, 2′-deoxyadenosine 5′-monophosphate: AMPK, CMP: (d)CMPK, GMP: GMPK, TMP: TMPK, and UMP: UMPK. The reactions were preheated to 37 °C and started by the addition of diluted enzyme stock solution. After 5 min, a 30 μl sample was stopped with 780 μl cold deionized water and analyzed by the luminescent assay.
Thin-layer chromatography (TLC)
After the reactions were stopped by freezing, 5 μl were spotted on a TLC plate. The running buffer consisted of deionized water, 25% ammonia, isopropanol and dioxan in a ratio of 1:4:5:0 (screening) or 4:3:2:4 (cascade reactions). The reaction compounds were identified by comparison to authentic standards under UV-light.
High-performance liquid chromatography
For HPLC analysis, samples were stopped with ice-cooled deionized water and freeze-thawed. After centrifugation (21,500g, 4 °C, 15 min), samples were analyzed with a KNAUER Azura or Agilent 1200 system using a Phenomenex (Aschaffenburg) reversed phase Kinetex EVO C18 column (250 × 4.6 mm) as previously described (8, 58). Briefly, samples were measured at 260 nm and 34 °C with a flow rate of 1 ml min−1. Isocratic elution was performed using 80% A (0.1 M KH2PO4/K2HPO4, 8 mM tetrabutylammonium bisulfate, pH ca. 5.4) and 20% B (70% A, 30% MeOH) for 4 min followed by a gradient to 40% A and 60% B over 10 min, to 38% A and 62% B in 12 min, and back to 80% A and 20% B in 0.5 min. Initial conditions were maintained for 2.5 min.
Enzyme cascade reactions were analyzed using an adapted gradient: after an isocratic step of 80% A and 20% B for 4 min, 100% B was obtained in 16 min and maintained for 10 min. Then, initial conditions were restored in 0.5 min and maintained for 9.5 min.
Typical retention times were as follows: AMP: 7.5 min, ADP: 14.6 min, ATP: 19.6 min. Substrates and products were identified based on their retention time and UV absorption spectra.
Conversions were calculated according to (1) as the ratio between the peak area of compound X (PX) and the sum of all peak areas of the substrate and product(s) in the reaction (Ptotal).
| (1) |
Luminescent assay
The luminescent assay was performed as previously described (58). Briefly, the luminescence of 90 μl sample and 10 μl Kinase-Glo Max reagent (Promega) was measured by a Tecan infinite M1000 plate reader. The product formation was calculated from the remaining ATP in the reaction according to formula (2), where is the average luminescence signal of the reaction sample, and is the average luminescence signal of the negative control.
| (2) |
Data availability
All data depicted visually in the items and in the main text as well as in the Supplementary Material are available on request from the corresponding author.
Supporting information
This article contains supporting information (Figures S1-S7; Tables S1-S3; and Refs. (14, 15, 16, 17, 18, 57, 59, 60, 61, 62, 63, 64, 65, 66, 67, 68, 69, 70, 71, 72, 73, 74)).
Conflict of interest
A. K. is CEO of the biotech company BioNukleo GmbH. M. F. and C. M. are scientists at BioNukleo GmbH, and P. N. is a member of the advisory board. The authors declare no conflict of interest.
Acknowledgments
We are grateful to the BioNukleo GmbH members Julia Schollmeyer and Sarah Westarp for their support in the lab. We thank Birgitte Munch-Petersen for suppling Drosophila melanogaster deoxynucleoside kinase plasmid. We acknowledge support by the Open Access Publication Fund of TU Berlin.
Author contributions
K. F. W., P. N., and A. K. conceptualization; K. F. W. and A. K. methodology; K. F. W., L. P., C. M., and J. H. validation; K. F. W., L. P., C. M., and J. H. formal analysis; K. F. W., L. P., C. M., and J. H. investigation; P. N. and A. K. resources; K. F. W. data curation; K. F. W., P. F., and A. K. writing—original draft preparation; K. F. W., L. P., C. M., M. F., P. N., A. K., and J. H. writing—review and editing; K. F. W., L. P., C. M., and A. K. visualization; K. F. W., M. F., P. N., and A. K. supervision; K. F. W., M. F., P. N., and A. K. project administration; P. N. and A. K. funding acquisition.
Funding and additional information
K. F. W. was funded by the Deutsche Forschungsgemeinschaft (DFG, German Research Foundation), grant number 392246628. This Project is supported by the Federal Ministry for Economic Affairs and Climate Action (BMWK) on the basis of a decision by the German Bundestag, project number ZF4184202SK9.
Reviewed by members of the JBC Editorial Board. Edited by Craig Cameron
Supporting information
References
- 1.Jordheim L.P., Durantel D., Zoulim F., Dumontet C. Advances in the development of nucleoside and nucleotide analogues for cancer and viral diseases. Nat. Rev. Drug Discov. 2013;12:447–464. doi: 10.1038/nrd4010. [DOI] [PubMed] [Google Scholar]
- 2.Ledesma-Amaro R., Jiménez A., Santos M.A., Revuelta J.L. Biotechnological production of feed nucleotides by microbial strain improvement. Process. Biochem. 2013;48:1263–1270. [Google Scholar]
- 3.Espinasse A., Lembke H.K., Cao A.A., Carlson E.E. Modified nucleoside triphosphates in bacterial research for in vitro and live-cell applications. RSC Chem. Biol. 2020;1:333–351. doi: 10.1039/d0cb00078g. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 4.Tregoning J.S., Flight K.E., Higham S.L., Wang Z., Pierce B.F. Progress of the COVID-19 vaccine effort: viruses, vaccines and variants versus efficacy, effectiveness and escape. Nat. Rev. Immunol. 2021;21:626–636. doi: 10.1038/s41577-021-00592-1. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 5.Corman V.M., Landt O., Kaiser M., Molenkamp R., Meijer A., Chu D.K., et al. Detection of 2019 novel coronavirus (2019-NCoV) by real-time RT-PCR. Euro Surveill. 2020;25 doi: 10.2807/1560-7917.ES.2020.25.3.2000045. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 6.Burgess K., Cook D. Syntheses of nucleoside triphosphates. Chem. Rev. 2000;100:2047–2059. doi: 10.1021/cr990045m. [DOI] [PubMed] [Google Scholar]
- 7.Faber K. In: Biotransformations in Organic Chemistry. Faber K., editor. Springer International Publishing; Cham: 2018. Biocatalytic applications; pp. 106–115. [Google Scholar]
- 8.Fehlau M., Kaspar F., Hellendahl K.F., Schollmeyer J., Neubauer P., Wagner A. Modular enzymatic cascade synthesis of nucleotides using a (d)ATP regeneration system. Front. Bioeng. Biotechnol. 2020;8:854. doi: 10.3389/fbioe.2020.00854. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 9.Frisch J., Maršić T., Loderer C. A novel one-pot enzyme cascade for the biosynthesis of cladribine triphosphate. Biomolecules. 2021;11:346. doi: 10.3390/biom11030346. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 10.Sharma S., Vaid S., Bhat B., Singh S., Bajaj B.K. In: Advances in Enzyme Technology. Singh R.S., Singhania R.R., Pandey A., Larroche C., editors. Elsevier; Amsterdam, The Netherlands: 2019. Chapter 17 - thermostable enzymes for industrial biotechnology; pp. 469–495. Biomass, Biofuels, Biochemicals. [Google Scholar]
- 11.Rigoldi F., Donini S., Redaelli A., Parisini E., Gautieri A. Review: engineering of thermostable enzymes for industrial applications. APL Bioeng. 2018;2 doi: 10.1063/1.4997367. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 12.Mehta R., Singhal P., Singh H., Damle D., Sharma A.K. Insight into thermophiles and their wide-spectrum applications. 3 Biotech. 2016;6:81. doi: 10.1007/s13205-016-0368-z. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 13.Del Arco J., Fernández-Lucas J. Purine and pyrimidine salvage pathway in thermophiles: a valuable source of biocatalysts for the industrial production of nucleic acid derivatives. Appl. Microbiol. Biotechnol. 2018;102:7805–7820. doi: 10.1007/s00253-018-9242-8. [DOI] [PubMed] [Google Scholar]
- 14.Hansen T., Schönheit P. Sequence, expression, and characterization of the first archaeal ATP-dependent 6-phosphofructokinase, a non-allosteric enzyme related to the phosphofructokinase-B sugar kinase family, from the Hyperthermophilic crenarchaeote Aeropyrum pernix. Arch. Microbiol. 2001;177:62–69. doi: 10.1007/s00203-001-0359-1. [DOI] [PubMed] [Google Scholar]
- 15.Hansen T., Arnfors L., Ladenstein R., Schönheit P. The phosphofructokinase-B (MJ0406) from Methanocaldococcus jannaschii represents a nucleoside kinase with a broad substrate specificity. Extremophiles. 2006;11:105. doi: 10.1007/s00792-006-0018-1. [DOI] [PubMed] [Google Scholar]
- 16.Aziz I., Bibi T., Rashid N., Aono R., Atomi H., Akhtar M. A phosphofructokinase homolog from Pyrobaculum calidifontis displays kinase activity towards pyrimidine nucleosides and ribose 1-phosphate. J. Bacteriol. 2018;200 doi: 10.1128/JB.00284-18. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 17.Elkin S.R., Kumar A., Price C.W., Columbus L. A broad specificity nucleoside kinase from Thermoplasma acidophilum. Proteins. 2013;81:568–582. doi: 10.1002/prot.24212. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 18.Lutz S., Lichter J., Liu L. Exploiting temperature-dependent substrate promiscuity for nucleoside analogue activation by thymidine kinase from Thermotoga maritima. J. Am. Chem. Soc. 2007;129:8714–8715. doi: 10.1021/ja0734391. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 19.Tozzi M.G., Camici M., Pesi R., Allegrini S., Sgarrella F., Ipata P.L. Nucleoside phosphotransferase activity of human colon carcinoma cytosolic 5’-nucleotidase. Arch. Biochem. Biophys. 1991;291:212–217. doi: 10.1016/0003-9861(91)90125-3. [DOI] [PubMed] [Google Scholar]
- 20.Mihara Y., Utagawa T., Yamada H., Asano Y. Acid phosphatase/phosphotransferases from enteric bacteria. J. Biosci. Bioeng. 2001;92:50–54. doi: 10.1263/jbb.92.50. [DOI] [PubMed] [Google Scholar]
- 21.Arnfors L., Hansen T., Schönheit P., Ladenstein R., Meining W. Structure of Methanocaldococcus jannaschii nucleoside kinase: an archaeal member of the ribokinase family. Acta Crystallogr. D Biol. Crystallogr. 2006;62:1085–1097. doi: 10.1107/S0907444906024826. [DOI] [PubMed] [Google Scholar]
- 22.Hildenbrand J.C., Teleki A., Jendrossek D. A universal polyphosphate kinase: PPK2c of Ralstonia eutropha accepts purine and pyrimidine nucleotides including uridine diphosphate. Appl. Microbiol. Biotechnol. 2020;104:6659–6667. doi: 10.1007/s00253-020-10706-9. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 23.Zhang R.-G., Skarina T., Katz J.E., Beasley S., Khachatryan A., Vyas S., et al. Structure of Thermotoga maritima stationary phase survival protein SurE: a novel acid phosphatase. Structure. 2001;9:1095–1106. doi: 10.1016/s0969-2126(01)00675-x. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 24.Rodionova I.A., Yang C., Li X., Kurnasov O.V., Best A.A., Osterman A.L., et al. Diversity and versatility of the Thermotoga maritima sugar kinome. J. Bacteriol. 2012;194:5552–5563. doi: 10.1128/JB.01136-12. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 25.Sakasegawa S., Hayashi J., Ikura Y., Ueda S., Imamura S., Kumazawa T., et al. Colorimetric inorganic pyrophosphate assay using a double cycling enzymatic method. Anal. Biochem. 2011;416:61–66. doi: 10.1016/j.ab.2011.04.043. [DOI] [PubMed] [Google Scholar]
- 26.Kilstrup M., Hammer K., Ruhdal Jensen P., Martinussen J. Nucleotide metabolism and its control in lactic acid bacteria. FEMS Microbiol. Rev. 2005;29:555–590. doi: 10.1016/j.femsre.2005.04.006. [DOI] [PubMed] [Google Scholar]
- 27.Bock A.K., Glasemacher J., Schmidt R., Schönheit P. Purification and characterization of two extremely thermostable enzymes, phosphate acetyltransferase and acetate kinase, from the hyperthermophilic eubacterium Thermotoga maritima. J. Bacteriol. 1999;181:1861–1867. doi: 10.1128/jb.181.6.1861-1867.1999. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 28.Johnsen U., Hansen T., Schönheit P. Comparative analysis of pyruvate kinases from the hyperthermophilic archaea Archaeoglobus fulgidus, Aeropyrum pernix, and Pyrobaculum aerophilum and the hyperthermophilic bacterium Thermotoga maritima: unusal regulatory properties in hyperthermophilic archaea. J. Biol. Chem. 2003;278:25417–25427. doi: 10.1074/jbc.M210288200. [DOI] [PubMed] [Google Scholar]
- 29.Zhang H., Ishige K., Kornberg A. A polyphosphate kinase (PPK2) widely conserved in bacteria. Proc. Natl. Acad. Sci. U. S. A. 2002;99:16678–16683. doi: 10.1073/pnas.262655199. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 30.Lott J.S., Paget B., Johnston J.M., Delbaere L.T.J., Sigrell-Simon J.A., Banfield M.J., et al. The structure of an ancient conserved domain establishes a structural basis for stable histidine phosphorylation and identifies a new family of adenosine-specific kinases. J. Biol. Chem. 2006;281:22131–22141. doi: 10.1074/jbc.M603062200. [DOI] [PubMed] [Google Scholar]
- 31.Tomoike F., Tsunetou A., Kim K., Nakagawa N., Kuramitsu S., Masui R. A putative adenosine kinase family protein possesses adenosine diphosphatase activity. Biosci. Biotechnol. Biochem. 2016;80:2138–2143. doi: 10.1080/09168451.2016.1214532. [DOI] [PubMed] [Google Scholar]
- 32.Wolf Y.I., Kondrashov A.S., Koonin E.V. Interkingdom gene fusions. Genome Biol. 2000;1 doi: 10.1186/gb-2000-1-6-research0013. research0013. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 33.Lu Q., Inouye M. Adenylate kinase complements nucleoside diphosphate kinase deficiency in nucleotide metabolism. Proc. Natl. Acad. Sci. U. S. A. 1996;93:5720–5725. doi: 10.1073/pnas.93.12.5720. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 34.Amiri M., Conserva F., Panayiotou C., Karlsson A., Solaroli N. The human adenylate kinase 9 is a nucleoside mono- and diphosphate kinase. Int. J. Biochem. Cell Biol. 2013;45:925–931. doi: 10.1016/j.biocel.2013.02.004. [DOI] [PubMed] [Google Scholar]
- 35.Wang L. The role of ureaplasma nucleoside monophosphate kinases in the synthesis of nucleoside triphosphates. FEBS J. 2007;274:1983–1990. doi: 10.1111/j.1742-4658.2007.05742.x. [DOI] [PubMed] [Google Scholar]
- 36.Ye D., Wei M., McGuire M., Huang K., Kapadia G., Herzberg O., et al. Investigation of the catalytic site within the ATP-grasp domain of Clostridium symbiosum pyruvate phosphate dikinase. J. Biol. Chem. 2001;276:37630–37639. doi: 10.1074/jbc.M105631200. [DOI] [PubMed] [Google Scholar]
- 37.Sakai H., Suzuki K., Imahori K. Purification and properties of pyruvate kinase from Bacillus stearothermophilus. J. Biochem. 1986;99:1157–1167. doi: 10.1093/oxfordjournals.jbchem.a135579. [DOI] [PubMed] [Google Scholar]
- 38.Nakajima H., Suzuki K., Imahori K. Purification and properties of acetate kinase from Bacillus stearothermophilus. J. Biochem. 1978;84:193–203. doi: 10.1093/oxfordjournals.jbchem.a132108. [DOI] [PubMed] [Google Scholar]
- 39.Deville-Bonne D., El Amri C., Meyer P., Chen Y., Agrofoglio L.A., Janin J. Human and Viral Nucleoside/Nucleotide Kinases Involved in Antiviral Drug Activation: Structural and Catalytic Properties. Antiviral Res. 2010;86:101–120. doi: 10.1016/j.antiviral.2010.02.001. [DOI] [PubMed] [Google Scholar]
- 40.Martínez-Botella G., Breen J.N., Duffy J.E.S., Dumas J., Geng B., Gowers I.K., et al. Discovery of selective and potent inhibitors of gram-positive bacterial thymidylate kinase (TMK) J. Med. Chem. 2012;55:10010–10021. doi: 10.1021/jm3011806. [DOI] [PubMed] [Google Scholar]
- 41.Sinha K., Rule G.S. The structure of thymidylate kinase from Candida albicans reveals a unique structural element. Biochemistry. 2017;56:4360–4370. doi: 10.1021/acs.biochem.7b00498. [DOI] [PubMed] [Google Scholar]
- 42.Kandeel M., Kitade Y. Molecular characterization, heterologous expression and kinetic analysis of recombinant Plasmodium falciparum thymidylate kinase. J. Biochem. 2008;144:245–250. doi: 10.1093/jb/mvn062. [DOI] [PubMed] [Google Scholar]
- 43.Zinchenko A.I., Barai V.N., Zaiashko L.M., Poopeiko N.E., Pricota T.I., Sivets G.G., et al. Enzymatic synthesis of nucleoside 5′-mono and -triphosphates. FEBS Lett. 1990;260:254–256. [Google Scholar]
- 44.Imazawa M., Eckstein F. Synthesis of sugar-modified nucleoside 5’-triphosphates with partially purified nucleotide kinases from calf thymus. Biochim. Biophys. Acta. 1979;570:284–290. doi: 10.1016/0005-2744(79)90148-7. [DOI] [PubMed] [Google Scholar]
- 45.Hennig M., Scott L.G., Sperling E., Bermel W., Williamson J.R. Synthesis of 5-fluoropyrimidine nucleotides as sensitive NMR probes of RNA structure. J. Am. Chem. Soc. 2007;129:14911–14921. doi: 10.1021/ja073825i. [DOI] [PubMed] [Google Scholar]
- 46.Eckstein F., Goody R.S. Synthesis and properties of diastereoisomers of adenosine 5’-(O-1-thiotriphosphate) and adenosine 5’-(O-2-thiotriphosphate) Biochemistry. 1976;15:1685–1691. doi: 10.1021/bi00653a015. [DOI] [PubMed] [Google Scholar]
- 47.Kim M.-J., Whitesides G.M. Enzyme-catalyzed synthesis of nucleoside triphosphates from nucleoside monophosphates. Appl. Biochem. Biotechnol. 1987;16:95–108. [Google Scholar]
- 48.Panayiotou C., Solaroli N., Karlsson A. The many isoforms of human adenylate kinases. Int. J. Biochem. Cell Biol. 2014;49:75–83. doi: 10.1016/j.biocel.2014.01.014. [DOI] [PubMed] [Google Scholar]
- 49.Saint Girons I., Gilles A.M., Margarita D., Michelson S., Monnot M., Fermandjian S., et al. Structural and catalytic characteristics of Escherichia coli adenylate kinase. J. Biol. Chem. 1987;262:622–629. [PubMed] [Google Scholar]
- 50.Bertrand T., Briozzo P., Assairi L., Ofiteru A., Bucurenci N., Munier-Lehmann H., et al. Sugar specificity of bacterial CMP kinases as revealed by crystal structures and mutagenesis of Escherichia coli enzyme. J. Mol. Biol. 2002;315:1099–1110. doi: 10.1006/jmbi.2001.5286. [DOI] [PubMed] [Google Scholar]
- 51.Pfeiffer M., Nidetzky B. Reverse C-glycosidase reaction provides C-nucleotide building blocks of xenobiotic nucleic acids. Nat. Commun. 2020;11:6270. doi: 10.1038/s41467-020-20035-0. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 52.Johansson M., Amiri M., Karlsson A. Phosphorylation of 9-β-d-arabinofuranosylguanine monophosphate by Drosophila melanogaster guanylate kinase. Biochem. Pharmacol. 2005;70:987–992. doi: 10.1016/j.bcp.2005.06.023. [DOI] [PubMed] [Google Scholar]
- 53.Agarwal R.P., Scholar E.M., Agarwal K.C., Parks R.E. Identification and isolation on a large scale of guanylate kinase from human erythrocytes: effects of monophosphate nucleotides of purine analogs. Biochem. Pharmacol. 1971;20:1341–1354. doi: 10.1016/0006-2952(71)90261-9. [DOI] [PubMed] [Google Scholar]
- 54.Miller W.H., Miller R.L. Phosphorylation of acyclovir (acycloguanosine) monophosphate by GMP kinase. J. Biol. Chem. 1980;255:7204–7207. [PubMed] [Google Scholar]
- 55.Boehme R.E. Phosphorylation of the antiviral precursor 9-(1,3-dihydroxy-2-propoxymethyl)guanine monophosphate by guanylate kinase isozymes. J. Biol. Chem. 1984;259:12346–12349. [PubMed] [Google Scholar]
- 56.Munch-Petersen B., Knecht W., Lenz C., Søndergaard L., Piškur J. Functional expression of a multisubstrate deoxyribonucleoside kinase from Drosophila melanogaster and its C-terminal deletion mutants. J. Biol. Chem. 2000;275:6673–6679. doi: 10.1074/jbc.275.9.6673. [DOI] [PubMed] [Google Scholar]
- 57.Kaspar F., Wolff D.S., Neubauer P., Kurreck A., Arcus V.L. PH-independent heat capacity changes during phosphorolysis catalyzed by the pyrimidine nucleoside phosphorylase from Geobacillus thermoglucosidasius. Biochemistry. 2021;60:1573–1577. doi: 10.1021/acs.biochem.1c00156. [DOI] [PubMed] [Google Scholar]
- 58.Hellendahl K.F., Fehlau M., Hans S., Neubauer P., Kurreck A. Semi-automated high-throughput substrate screening assay for nucleoside kinases. Int. J. Mol. Sci. 2021;22:11558. doi: 10.3390/ijms222111558. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 59.Li Z., Ning X., Zhao Y., Zhang X., Xiao C., Li Z. Efficient one-pot synthesis of cytidine 5’-monophosphate using an extremophilic enzyme cascade system. J. Agric. Food Chem. 2020;68:9188–9194. doi: 10.1021/acs.jafc.0c04055. [DOI] [PubMed] [Google Scholar]
- 60.Blöndal T., Thorbjarnardóttir S.H., Kieleczawa J., Einarsson J.M., Hjörleifsdóttir S., Kristjánssonand J.K., et al. Cloning, sequence analysis and overexpression of a Rhodothermus Marinus gene encoding a thermostable thymidine kinase. FEMS Microbiol. Lett. 1993;179:311–316. doi: 10.1111/j.1574-6968.1999.tb08743.x. [DOI] [PubMed] [Google Scholar]
- 61.Tomoike F., Nakagawa N., Kuramitsu S., Masui R. A single amino acid limits the substrate specificity of Thermus Thermophilus uridine-cytidine kinase to cytidine. Biochemistry. 2011;50:4597–4607. doi: 10.1021/bi102054n. [DOI] [PubMed] [Google Scholar]
- 62.Tomoike F., Nakagawa N., Kuramitsu S., Masui R. Structural and biochemical studies on the reaction mechanism of uridine-cytidine kinase. Protein J. 2015;34:411–420. doi: 10.1007/s10930-015-9636-8. [DOI] [PubMed] [Google Scholar]
- 63.Haney P.J., Stees M., Konisky J. Analysis of thermal stabilizing interactions in mesophilic and thermophilic adenylate kinases from the genus Methanococcus. J. Biol. Chem. 1999;274:28453–28458. doi: 10.1074/jbc.274.40.28453. [DOI] [PubMed] [Google Scholar]
- 64.Konisky J., Michels P.C., Clark D.S. Pressure stabilization is not a general property of thermophilic enzymes: the adenylate kinases of Methanococcus Voltae, Methanococcus Maripaludis, Methanococcus Thermolithotrophicus, and Methanococcus Jannaschii. Appl. Environ. Microbiol. 1995;61:2762–2764. doi: 10.1128/aem.61.7.2762-2764.1995. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 65.Rusnak P., Haney P., Konisky J. The adenylate kinases from a mesophilic and three thermophilic methanogenic members of the archaea. J. Bacteriol. 1995;177:2977–2981. doi: 10.1128/jb.177.11.2977-2981.1995. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 66.Vieille C., Krishnamurthy H., Hyun H.-H., Savchenko A., Yan H., Zeikus J.G. Thermotoga Neapolitana adenylate kinase is highly active at 30 degrees C. Biochem. J. 2003;372:577–585. doi: 10.1042/BJ20021377. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 67.Mega R., Nakagawa N., Kuramitsu S., Masui R. The crystal structures of Thermus Thermophilus CMP kinase complexed with a phosphoryl group acceptor and donor. PLoS One. 2020;15 doi: 10.1371/journal.pone.0233689. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 68.Biswas A., Shukla A., Chaudhary S.K., Santhosh R., Jeyakanthan J., Sekar K. Structural studies of a hyperthermophilic thymidylate kinase enzyme reveal conformational substates along the reaction coordinate. FEBS J. 2017;284:2527–2544. doi: 10.1111/febs.14140. [DOI] [PubMed] [Google Scholar]
- 69.Chaudhary S.K., Jeyakanthan J., Sekar K. Cloning, expression, purification, crystallization and preliminary x-ray crystallographic study of thymidylate kinase (TTHA1607) from Thermus Thermophilus HB8. Acta Crystallogr. Sect. F. 2013;69:118–121. doi: 10.1107/S1744309112050208. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 70.Biswas A., Shukla A., Vijayan R.S.K., Jeyakanthan J., Sekar K. Crystal structures of an archaeal thymidylate kinase from Sulfolobus Tokodaii provide insights into the role of a conserved active site arginine residue. J. Struct. Biol. 2017;197:236–249. doi: 10.1016/j.jsb.2016.12.001. [DOI] [PubMed] [Google Scholar]
- 71.Marco-Marín C., Escamilla-Honrubia J.M., Rubio V. First-time crystallization and preliminary x-ray crystallographic analysis of a bacterial-archaeal type ump kinase, a key enzyme in microbial pyrimidine biosynthesis. Biochim. Biophys. Acta - Proteins Proteomics. 2005;1747:271–275. doi: 10.1016/j.bbapap.2004.11.010. [DOI] [PubMed] [Google Scholar]
- 72.Jensen K.S., Johansson E., Jensen K.F. Structural and enzymatic investigation of the Sulfolobus Solfataricus uridylate kinase shows competitive UTP inhibition and the lack of GTP stimulation. Biochemistry. 2007;46:2745–2757. doi: 10.1021/bi0618159. [DOI] [PubMed] [Google Scholar]
- 73.Takeishi S., Nakagawa N., Maoka N., Kihara M., Moriguchi M., Masui R., et al. Crystallization and preliminary x-ray diffraction studies of nucleoside diphosphate kinase from Thermus Thermophilus HB8. Acta Crystallogr. D. Biol. Crystallogr. 2003;59:1843–1845. doi: 10.1107/s0907444903017712. [DOI] [PubMed] [Google Scholar]
- 74.Pédelacq J.-D., Piltch E., Liong E.C., Berendzen J., Kim C.-Y., Rho B.-S., et al. Engineering soluble proteins for structural genomics. Nat. Biotechnol. 2002;20:927–932. doi: 10.1038/nbt732. [DOI] [PubMed] [Google Scholar]
Associated Data
This section collects any data citations, data availability statements, or supplementary materials included in this article.
Supplementary Materials
Data Availability Statement
All data depicted visually in the items and in the main text as well as in the Supplementary Material are available on request from the corresponding author.




